Navigation Links
Detroit Medical Center Shares Smart Room Case Study at CHIME 2011 Fall CIO Forum
Date:10/25/2011

TROY, Mich., Oct. 25, 2011 /PRNewswire/ -- CareTech Solutions, an information technology (IT) and Web products and services provider for over 180 U.S. hospitals announced today that the company's client, Mike LeRoy, senior vice president and chief information officer, Detroit Medical Center (DMC), Vanguard Health System (VHS) of Michigan will present an educational session at the 2011 College of Health Information Management Executives (CHIME) Fall CIO Forum taking place Oct. 25 – 28 in San Antonio, Texas.  The session titled, Smart Rooms: Increasing Clinical Efficiency and Patient Safety, explores the use of clinical software technology linked to medical devices and workflow solutions for improved safety, quality and efficiency of patient care.

"DMC, a five times Most Wired hospital winner, implemented an electronic medical record (EMR) several years ago and the hospital is now strategically using technology to improve patient care and streamline processes," said Jim Giordano, president and CEO, CareTech Solutions. "CareTech Solutions is honored to be DMC's information technology partner and pleased to support them in sharing their IT experiences with the prestigious CHIME audience."

About the Detroit Medical Center

The Detroit Medical Center operates 9 hospitals and institutes, including Children's Hospital of Michigan, Detroit Receiving Hospital and University Health Center, Harper University Hospital, Huron Valley-Sinai Hospital, Hutzel Women's Hospital, Michigan Orthopaedic Specialty Hospital, Rehabilitation Institute of Michigan, Sinai-Grace Hospital, Kresge Eye Institute and is in partnership with Karmanos Cancer Institute.

Established as a nonprofit corporation in 1985, the Detroit Medical Center is a leading regional health care system with a mission of excellence in clinical care, research and medical education. The Detroit Medical Center is the academic health center for Wayne State Universit
'/>"/>

SOURCE CareTech Solutions
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
2. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
3. Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative
4. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
5. Detroit Medical Center Chooses CareTech Solutions Document Imaging System
6. Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
7. Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Attack in High-Risk Patients
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Globus Medical Raises $110 Million in Series E Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
(Date:8/28/2015)... Aug. 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... completed the acquisition of leading OTC brands from GSK ... The transaction is a clear demonstration of Perrigo,s unique ... European distribution network spanning 36 countries.  ... commented, "We are excited to complete this transaction, ...
(Date:8/28/2015)... , August 28, 2015 The ... Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ( ... Asia-Pacific , and Rest of the World) ... The global market for Eubiotics was valued at USD 4.62 ... Billion by 2020, at a CAGR of 7.4% from 2015 ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... 2011 Nektar Therapeutics (Nasdaq: NKTR ) ... 2 clinical study of NKTR-102 in patients with metastatic ... Cancer Symposium in San Francisco, California.  NKTR-102 is a ... conjugate technology, and is being developed in multiple tumor ...
... The Board of the European Fine Chemicals ... to ratify the proposal of the US Food and Drug ... the help of EFCG and US industry representatives, to deliver ... (GDUFA). GDUFA requires the FDA to commit to ...
Cached Medicine Technology:Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium 2Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium 3Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium 4Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium 5Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium 6European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA) 2
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor in the City, ... added yet another accolade to its cadre of widespread support—an official letter of support ... help of the medical community and the University of Illinois at Chicago’s Department of ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this software allows businesses to track product movement from beginning to end. , Businesses ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville Business ... veterans leading in business. Mr. Troy Mizell, Chairman of the Board at ... Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, through their ...
(Date:8/28/2015)... ... ... The Quatela Center for Plastic Surgery is excited to bring patients the ... by the Food and Drug Administration to eliminate submental fat, also known as the ... are among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     , ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... for those seeking to go deep sea diving. The act of recreational ... decompression sickness; for these reasons, it is vital that all recreational and professional ...
Breaking Medicine News(10 mins):Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Healthpointe Now Offering Scuba Physicals 2
... Vancouver Career College ... ... Career College in Surrey are digging through their closets to find clothing to. Now they’re ... need., , , , ,“Every day we focus on building a community here on campus ...
... Research Hospital and the University of Florida Proton Therapy Institute ... Jude patients. The announcement follows the approval of the first ... rare brain cancers in children younger than 3 years old. ... refer patients to receive proton therapy at the UF Proton ...
... Bright Horizons Family Solutions® today announced that it ... by the Boston Globe. The prestigious ranking on the Globe ... has always worked to support its employees and despite the ... on fostering a culture where employees feel valued and supported at ...
... computerized alerts can help curb the impulse to ... in the August issue of Journal of ... received computerized alerts, which compared medication brands, they ... marketed sleep medications to comparable generic equivalents. ...
... of those hurt are under 16, researchers say , MONDAY, ... the United States in recent years, rising by 160 percent ... , However, the total number of injuries related to hot ... remains fairly small at about 6,600 per year. , ...
... today the acquisition of App Tech Global, Inc., which will ... Nutrition,s name will be changed to App Tech, Corp. and ... App Tech Global, Inc. , App Tech is developing mobile ... App Tech is focused on multi platform apps designed to ...
Cached Medicine News:Health News:Surrey College Students Collect Clothing for Women and Children 2Health News:St. Jude Children's Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 2Health News:St. Jude Children's Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 3Health News:St. Jude Children's Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 4Health News:Bright Horizons Named One of Boston Globe 100's Top Places to Work 2Health News:Computerized support keeps prominence of name brand drugs at bay 2Health News:Hot-Tub Injuries on the Rise 2
... We offer a complete ... bringing laboratorians state-of-the-art monoclonal and ... the detection of enteric pathogens ... includes products for Clostridium difficile, ...
... is a second-generation rapid ELISA for the detection ... fecal specimens. The test utilizes highly specific antibodies ... the more common toxin A+ samples, but also ... perform, produces no indeterminates and provides results in ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
Medicine Products: